Exploration of the DPP-4 inhibitors with a focus on saxagliptin

Author： Shubrook Jay H Colucci Randall A Schwartz Frank L

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.10, Iss.17, 2009-12, pp. : 2927-2934

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic analysis of DPP-4 inhibitors

By Teramachi H. Ohta H. Tachi T. Toyoshima M. Mizui T. Goto C. Tsuchiya T.

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 909-915

Govi-Verlag

Access to resources Recommend Favorite

Structure Based Lead Optimization Approach in Discovery of Selective DPP4 Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 6, 2013-05 ,pp. : 888-914

Bentham Science Publishers

Access to resources Recommend Favorite

In Silico Study of Flavonoids as DPP-4 and #945;-glucosidase Inhibitors

Letters in Drug Design & Discovery, Vol. 15, Iss. 6, 2018-04 ,pp. : 634-642

Bentham Science Publishers

Access to resources Recommend Favorite

Saxagliptin overview: special focus on safety and adverse effects

By Ali Shamsa Fonseca Vivian

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 103-109

Informa Healthcare

Access to resources Recommend Favorite

Saxagliptin

By Dhillon Sohita Weber Juliane

Drugs, Vol. 69, Iss. 15, 2009-10 ,pp. : 2103-2114

Adis International

Access to resources Recommend Favorite